Metabolic Syndrome and NASH: Risk for HCC

被引:0
作者
不详
机构
来源
DIABETES STOFFWECHSEL UND HERZ | 2022年 / 31卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:190 / 190
页数:1
相关论文
共 50 条
  • [41] T cell drivers in NASH-HCC
    O'Leary, Karen
    NATURE REVIEWS CANCER, 2021, 21 (06) : 341 - 341
  • [42] Mitochondrial Dysfunction in the Transition from NASH to HCC
    Leveille, Melissa
    Estall, Jennifer L.
    METABOLITES, 2019, 9 (10)
  • [43] HCC and NASH: How strong is the clinical demonstration?
    Rosmorduc, O.
    Fartoux, L.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (03) : 202 - 208
  • [44] Metabolic syndrome marker profile in patients with hepatocellular carcinoma HCC.
    Guler, Nil
    Scaglione, Steve
    Syed, Daneyal
    Martin, Danyelle
    Hoppensteadt, Debra
    Saluk, Jennifer
    Sandhu, Jasmin
    Palumbo, Rachel
    Layden, Thomas
    Iqbal, Omer M.
    Fareed, Jawed
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH
    Geh, Daniel
    Gil, Erik Ramon
    Laszczewska, Maja
    Collins, Amy
    Luli, Saimir
    Cameron, Rainie
    Oakley, Fiona
    Leslie, Jack
    Reeves, Helen Louise
    Mann, Derek A.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S538 - S539
  • [46] Anti-NASH Effects of Solithromycin in NASH-HCC Mouse Model
    Fernandes, Prabhavathi
    Hashiguchi, Taishi
    Fujii, Masato
    Yoneyama, Hiroyuki
    GASTROENTEROLOGY, 2014, 146 (05) : S145 - S146
  • [47] Disordered hepatic cholesterol turnover in mice with metabolic syndrome: relationship to NASH
    Van Rooyen, D. M.
    Larter, C. Z.
    Teoh, N.
    Farrell, G. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A280 - A280
  • [48] Non-alcoholic steatohepatitis (NASH) transplant recipients are at high risk for hepatocellular carcinoma (HCC)
    Hernandez-Alejandro, Roberto
    Quan, Douglas
    Wall, William J.
    Dale, Cheryl H.
    Marotta, Paul J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 384 - 384
  • [49] The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality
    Ramy Younes
    Elisabetta Bugianesi
    Current Hepatology Reports, 2018, 17 (4) : 336 - 344
  • [50] ROLE OF DIETARY INTERVENTION IN PATIENTS WITH METABOLIC SYNDROME AND NAFLD-NASH
    Formisano, E.
    Pasta, A.
    Cremonini, A. L.
    Garrubba, C.
    Borro, P.
    Picciotto, A.
    Pisciotta, L.
    ATHEROSCLEROSIS, 2020, 315 : E262 - E262